Summary
The inhibitory action of a range ofβ-carbolines on human and rat monoamine oxidase (MAO) A and B has been studied. Concentrations of 5-hydroxytryptamine and phenylethylamine, approximately at their Km values, were used as substrates for MAO A and B respectively. A wide variation in selectivity was found, with harmaline being 10,000 times more potent an inhibitor of A than B whereas, using tetrahydro-β-carboline and harmane, the difference was nearer to ten-fold. Of the carbolines which have been found endogenously, tetrahydro-β-carboline, 6-methoxytetrahydro-β-carboline and harmane are all sufficiently potent inhibitors of human MAO A, with I50 values of 5×10−6, 10−6, 5×10−7M respectively, for this property to be of possible physiological significance. Harmane, with an I50 of 5×10−6M, might also play a role as an inhibitor of MAO B.
Similar content being viewed by others
References
Airaksinen, M. M., Kari, I.:β-Carbolines, psychoactive compounds in the mammalian body. Med. Biol.59, 21–23 (1981).
Barker, S. A., Harrison, R. E. W., Monti, J. A., Brown, G. B., Christian, S. T.: Identification and quantification of 1, 2, 3, 4-tetrahydro-β-carboline, 2-methyl-1, 2, 3, 4-tetrahydro-β-carboline, and 6-methoxy-1, 2, 3, 4-tetrahydro-β-carboline asin vivo constituents of rat brain and adrenal gland. Biochem. Pharmac.30, 9–17 (1981).
Bidder, T. G., Shoemaker, D. W., Boettger, H. G., Evans, M., Cummins, J. T.: Harman in human platelets. Life Sci.25, 157–164 (1979).
Braestrup, C., Nielsen, M., Olsen, C. E.: Urinary and brainβ-carboline-3-carboxylates as potent inhibitors of brain benzodiazepine receptors. Proc. Nat. Acad. Sci. U.S.A.77, 2288–2292 (1980).
Buckholtz, N. S., Boggan, W. O.: Monoamine oxidase inhibition in brain and liver produced byβ-carbolines: structure-activity relationships and substrate specificity. Biochem. Pharmac.26, 1991–1996 (1977).
Donnelly, C. H., Murphy, D. L.: Substrate- and inhibitor-related characteristics of human platelet monoamine oxidase. Biochem. Pharmac.26, 853–858 (1977).
Edwards, D. J., Chang, S. S.: Multiple forms of monoamine oxidase in rabbit platelets. Life Sci.17, 1127–1134 (1975).
Egashira, T.: Studies on monoamine oxidase. XVII. Enzymic properties of placental monoamine oxidase. Jap. J. Pharmac.26, 493–500 (1976).
Elsworth, J., Glover, V., Sandler, M.:tele-Methylhistamine is a specific MAO B substrate in man. Psychopharmacology69, 287–290 (1980).
Glover, V., Bhattacharya, S. K., Sandler, M., File, S. E.: Benzodiazepines reduce stress-augmented increase in rat urine monoamine oxidase inhibitor. Nature (London)292, 347–349 (1981a).
Glover, V., Peatfield, R., Zammit-Pace, R., Littlewood, J., Gawel, M., Rose, F. C., Sandler, M.: Platelet monoamine oxidase activity and headache. J. Neurol. Neurosurg. Psychiat.44, 786–790 (1981 b).
Glover, V., Reveley, M. A., Sandler, M.: A monoamine oxidase inhibitor in human urine. Biochem. Pharmac.29, 467–470 (1980).
Ho, B. T., McIsaac, W. M., Walker, K. E.: Inhibitors of monoamine oxidase II. Syntheses of some N-2(9)-substituted tetrahydro-β-carbolines and evaluation of their inhibitory activities. J. Pharm. Sci.57, 1364–1369 (1968 a).
Ho, B. T., McIsaac, W. M., Walker, K. E., Estevez, V.: Inhibitors of monoamine oxidase. J. Pharm. Sci.57, 269–272 (1968 b).
Honecker, H., Coper, H., Fähndrich, C., Rommelspacher, H.: Tetrahydronorharmane (tetrahydro-β-carboline) in human blood platelets. J. Clin. Chem. Clin. Biochem.18, 133–135 (1980).
Hunkeler, W., Möhler, H., Pieri, L., Polc, P., Bonnetti, E. P., Cumin, R., Schaffner, R., Haefely, W.: Selective antagonists of benzodiazepines. Nature (London)290, 514–515 (1981).
Lewinsohn, R., Glover, V., Sandler, M.:β-Phenylethylamine and benzylamine as substrates for human monoamine oxidase A: a source of some anomalies? Biochem. Pharmac.29, 777–781 (1980).
Meller, E., Friedman, E., Schweitzer, J. W., Friedhoff, A. J.: Tetrahydro-β-carbolines: specific inhibitors of type A monoamine oxidase in rat brain. J. Neurochem.28, 995–1000 (1977).
Nelson, D. L., Herbet, A., Pétillot, Y., Pichat, L., Glowinski, J., Hamon, M.: [3H]Harmaline as a specific ligand of MAO A-I. Properties of the active site of MAO A from rat and bovine brains. J. Neurochem.32, 1817–1827 (1979).
Owen, F., Cross, A. J., Lofihouse, R., Glover, V.: Distribution and inhibition characteristics of human brain monoamine oxidase. Biochem. Pharmac.28, 1077–1080 (1979).
Petursson, H., Bhattacharya, S. K., Glover, V., Sandler, M., Lader, M. H.: Urinary monoamine oxidase inhibitor and benzodiazepine withdrawal. Br. J. Psychiat.140, 7–10 (1982).
Petursson, H., Reveley, M. A., Glover, V., Sandler, M.: Urinary MAO inhibitor in psychiatric illness. Psychiat. Res.5, 335–340 (1981).
Peura, P., Kari, I., Airaksinen, M. M.: Identification by selective ion monitoring of 1-methyl 1, 2, 3, 4-tetrahydro-β-carboline in human platelets and plasma after ethanol intake. Biomed. Mass. Spectrom.7, 553–555 (1980).
Rommelspacher, H., Honecker, H., Barbey, M., Meinke, B.: 6-Hydroxytetrahydronorharmane (6-hydroxy-tetrahydro-β-carboline), a new active metabolite of indole-alkylamines in man and rat. Naunyn-Schmiedeberg's Arch. Pharmac.310, 35–41 (1979).
Rommelspacher, H., Nanz, C., Borbe, H. O., Fehske, K. J., Müller, W. E., Wollert, U.: 1-Methyl-β-carboline (harmane), a potent endogenous inhibitor of benzodiazepine receptor binding. Naunyn-Schmiedeberg's Arch. Pharmac.314, 97–100 (1980 a).
Rommelspacher, H., Strauss, S., Lindemann, J.: Excretion of tetrahydroharmane and harmane into the urine of man and rat after a load of ethanol. FEBS Letts.109, 209–212 (1980 b).
Sandler, M., Reveley, M. A., Glover, V.: Human platelet monoamine oxidase activity in health and disease: a review. J. clin. Path.34, 292–302 (1981).
Shoemaker, D. W., Cummins, J. T., Bidder, T. G., Boettiger, H. G., Evans, M.: Identification of harman in the rat arcuate nucleus. Naunyn-Schmiedeberg's Arch. Pharmac.310, 227–230 (1980).
Sparks, D. L., Buckholtz, N. S.: 6-Methoxy 1, 2, 3, 4-tetrahydro-β-carboline: a specific monoamine oxidase-A inhibitor in CF-1 mouse brain. Neurosci. Lett.20, 73–79 (1980).
Youdim, M. B. H., Oppenheim, B.: The effect of tryptolines (1, 2, 3, 4-tetrahydro-β-carbolines) on monoamine metabolism and the platelet aggregation response in human platelets. Neuroscience6, 801 (1981).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Glover, V., Liebowitz, J., Armando, I. et al. β-Carbolines as selective monoamine oxidase inhibitors:In vivo implications. J. Neural Transmission 54, 209–218 (1982). https://doi.org/10.1007/BF01254930
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01254930